An Array of Diagnostic Information at Your Fingertips
TruArray MRSA assay, in conjunction with components of the TruDiagnosis System, is a qualitative in vitro diagnostic test for the direct detection of nasal colonization by Staphylococcus aureus (SA) and methicillin-resistant Staphylococcus aureus (MRSA) to aid in the prevention and control of MRSA infections in healthcare settings. The test utilizes a single-tube, asymmetric polymerase chain reaction (PCR) for the simultaneous amplification and fluorescent labeling of SA/MRSA DNA that is recovered from a nasal swab specimen.
Sensitive and specific differentiation between MRSA and MSSA.
| Catalog # | Product Name & Description |
|---|---|
| 200-10500 | TruArray MRSA test for the direct detection of nasal colonization by Staphylococcus aureus (SA) and methicillin-resistant Staphylococcus aureus (MRSA). Includes primers, buffers and reagents to perform 10 tests. |
| Catalog # | Product Name & Description |
|---|---|
| 100-10000 | TruDiagnosis System for multiplexed molecular diagnosis. Includes the Akonni TruDx 1000 Reader, Akonni TruCycler Satellite Thermal Cycler, and laptop computer with data collection and analysis software. Systems include one year warranty against defective parts. Accepts international AC; 90-264V, 50-60 Hz AC. |
| 300‐10200 | TruTip DNA/RNA Kit (60 SPT) includes enough TruTip SPT tips to perform 60 extractions on less viscous samples. |
| 300‐10202 | TruTip DNA/RNA Kit (240 SPT) includes enough TruTip SPT tips to perform 240 extractions on less viscous samples. |
| 300‐10201 | TruTip DNA/RNA Kit (60 LPT) includes enough TruTip LPT tips to perform 60 extractions on more viscous samples. |
| 300‐10203 | TruTip DNA/RNA Kit (240 LPT) includes enough TruTip LPT tips to perform 240 extractions on more viscous samples. |
* All of Akonni Biosystems tests are currently for Research Use Only, and are not for use in diagnostic procedures. Akonni is interacting with the Food & Drug Administration (FDA) in order to develop and prepare pre-market notifications seeking clearance to market these products as diagnostic assays in the U.S.
